Current
Research in
Ophthalmology >>

The Age-Related Eye Disease Study II (AREDS II): A Multi-center, Randomized Trial of Lutein, Zeaxanthin, and Long-Chain Omega-3 Fatty Acids (Docosahexaenoic acid [DHA] and Eicosapentaenoic acid [EPA]) in Age-Related Macular Degeneration

Principal Investigator

Richard Rosen, MD

Enrollment Status

Completed

Objective

A Phase III randomized clinical trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and/or omega-3 Long Chain Poly Unsaturated Fatty Acids (LCPUFAs) as a treatment for AMD, cataract and moderate vision loss.

Study Results are currently being analyzed. Please visit this webpage next month for the study update. For more information: ClinicalTrials.gov